Cargando…
Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex
Captopril is the first angiotensin I-converting enzyme inhibitor widely used for the treatment of hypertension. Based on the well-known benefits of cyclodextrin inclusion complexes, the present study investigated the ability of β-cyclodextrin to include captopril. Solid inclusion complexes of captop...
Autores principales: | Musuc, Adina Magdalena, Anuta, Valentina, Atkinson, Irina, Popa, Vlad Tudor, Sarbu, Iulian, Mircioiu, Constantin, Abdalrb, Ghaleb Abdalameer, Mitu, Mirela Adriana, Ozon, Emma Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464127/ https://www.ncbi.nlm.nih.gov/pubmed/32784691 http://dx.doi.org/10.3390/pharmaceutics12080744 |
Ejemplares similares
-
Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
por: Musuc, Adina Magdalena, et al.
Publicado: (2021) -
Manufacturing and Assessing the New Orally Disintegrating Tablets, Containing Nimodipine-hydroxypropyl-β-cyclodextrin and Nimodipine-methyl-β-cyclodextrin Inclusion Complexes
por: Novac, Marian, et al.
Publicado: (2022) -
Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets
por: Ozon, Emma Adriana, et al.
Publicado: (2022) -
Design and Evaluation of Orally Dispersible Tablets Containing Amlodipine Inclusion Complexes in Hydroxypropyl-β-cyclodextrin and Methyl-β-cyclodextrin
por: Novac, Marian, et al.
Publicado: (2022) -
In Vitro and In Vivo Evaluation of Different Solid Dosage Forms Containing Captopril
por: ABDALRB, G.A., et al.
Publicado: (2017)